Geoff Pocock
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Geoff Pocock
Founder, Non-Executive Director, was Chair 2019-2023 / Argenica Therapeutics
Most Notable Role
Geoff Pocock has over 15 years of experience in commercialisation, corporate finance and strategy. Mr Pocock also has significant experience as a corporate advisor and strategy consultant advising companies on commercialisation and IP management, business development, mergers and acquisitions strategy, and raising equity capital from private and public equity markets.
He spent several years as a research scientist in the biopharmaceutical industry in Australia and the UK.
Mr Pocock was the managing director of Hazer Group and partner of Mac Equity Partners.
He holds a Bachelor of Science (with first class honours) and a Bachelor of Law from the University of Western Australia, and a Postgraduate Diploma in Applied Finance and Investment from the Securities Institute of Australia.
He spent several years as a research scientist in the biopharmaceutical industry in Australia and the UK.
Mr Pocock was the managing director of Hazer Group and partner of Mac Equity Partners.
He holds a Bachelor of Science (with first class honours) and a Bachelor of Law from the University of Western Australia, and a Postgraduate Diploma in Applied Finance and Investment from the Securities Institute of Australia.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 10th | Arovella Therapeutics | 432% | 110% |
| 158th | EMvision Medical Devices | 64% | 40% |
| 1006th | Hexima | -19% | |
| 1765th | OncoSil Medical | -72% | -44% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 828th |  | EMvision Medical Devices | $7.0m |
| 969th | | Antisense Therapeutics | $1.6m |
| 970th | | OncoSil Medical | $1.5m |
| 973rd | | Hexima | $1.5m |
| 974th | | Arovella Therapeutics | $1.5m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in Board Moves December 1, 2023 | 01 Dec 2023 |
| NEW ROLE: Founder, Non-Executive Director, was Chair 2019-2023, Argenica Therapeutics | 18 May 2021 |
| REMUNERATION UPDATE: Non-Executive Director, EMvision Medical Devices | 03 Nov 2020 |
